| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanoma | 22 | 2023 | 329 | 7.240 |
Why?
|
| Zebrafish | 28 | 2023 | 343 | 5.070 |
Why?
|
| Melanocytes | 12 | 2023 | 80 | 3.670 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2021 | 62 | 1.890 |
Why?
|
| Proto-Oncogene Proteins B-raf | 7 | 2022 | 51 | 1.650 |
Why?
|
| ras Proteins | 6 | 2017 | 77 | 1.260 |
Why?
|
| Skin Neoplasms | 4 | 2022 | 412 | 1.250 |
Why?
|
| Growth Differentiation Factor 6 | 2 | 2019 | 3 | 1.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2024 | 502 | 1.180 |
Why?
|
| Zebrafish Proteins | 6 | 2020 | 155 | 1.090 |
Why?
|
| Neural Crest | 3 | 2021 | 27 | 1.040 |
Why?
|
| Animals, Genetically Modified | 13 | 2021 | 289 | 0.960 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 4 | 2019 | 13 | 0.950 |
Why?
|
| Animals | 39 | 2024 | 20487 | 0.940 |
Why?
|
| Signal Transduction | 9 | 2023 | 3006 | 0.870 |
Why?
|
| Disease Models, Animal | 9 | 2024 | 2161 | 0.800 |
Why?
|
| Carcinogenesis | 2 | 2021 | 126 | 0.760 |
Why?
|
| Cell Differentiation | 5 | 2023 | 1339 | 0.750 |
Why?
|
| Mutation | 10 | 2022 | 2572 | 0.720 |
Why?
|
| Oncogenes | 4 | 2024 | 67 | 0.710 |
Why?
|
| Vitiligo | 1 | 2022 | 126 | 0.630 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2021 | 633 | 0.600 |
Why?
|
| Neoplasms | 4 | 2019 | 1343 | 0.580 |
Why?
|
| Melanosomes | 1 | 2017 | 1 | 0.580 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2017 | 9 | 0.570 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2017 | 32 | 0.560 |
Why?
|
| Caenorhabditis elegans Proteins | 5 | 2006 | 425 | 0.550 |
Why?
|
| Regeneration | 2 | 2015 | 95 | 0.540 |
Why?
|
| Cyclic AMP | 1 | 2017 | 143 | 0.540 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 283 | 0.500 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 223 | 0.500 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 213 | 0.480 |
Why?
|
| Genetic Variation | 1 | 2017 | 370 | 0.480 |
Why?
|
| Nevus | 4 | 2022 | 22 | 0.470 |
Why?
|
| Caenorhabditis elegans | 5 | 2006 | 675 | 0.470 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2023 | 205 | 0.440 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 1432 | 0.400 |
Why?
|
| Melanoma, Experimental | 1 | 2012 | 42 | 0.400 |
Why?
|
| Pigmentation | 4 | 2019 | 25 | 0.380 |
Why?
|
| Vulva | 4 | 2006 | 18 | 0.370 |
Why?
|
| Genes, Helminth | 3 | 2006 | 57 | 0.370 |
Why?
|
| Protein Methyltransferases | 1 | 2011 | 14 | 0.360 |
Why?
|
| Gene Amplification | 1 | 2011 | 24 | 0.360 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 32 | 0.360 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 69 | 0.350 |
Why?
|
| Hematopoiesis | 3 | 2017 | 122 | 0.340 |
Why?
|
| Humans | 21 | 2024 | 62321 | 0.320 |
Why?
|
| Skin | 2 | 2023 | 377 | 0.310 |
Why?
|
| Repressor Proteins | 4 | 2006 | 343 | 0.300 |
Why?
|
| Genes, APC | 1 | 2007 | 10 | 0.290 |
Why?
|
| Ligands | 2 | 2019 | 417 | 0.280 |
Why?
|
| Stem Cells | 3 | 2023 | 258 | 0.260 |
Why?
|
| Models, Animal | 3 | 2021 | 235 | 0.260 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 218 | 0.250 |
Why?
|
| HEK293 Cells | 2 | 2017 | 613 | 0.240 |
Why?
|
| TRPP Cation Channels | 1 | 2024 | 25 | 0.230 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2024 | 20 | 0.230 |
Why?
|
| Cell Adhesion Molecules | 1 | 2024 | 88 | 0.230 |
Why?
|
| Embryo, Nonmammalian | 4 | 2021 | 175 | 0.230 |
Why?
|
| MARVEL Domain-Containing Proteins | 1 | 2024 | 1 | 0.220 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2024 | 10 | 0.220 |
Why?
|
| Acetyltransferases | 1 | 2004 | 27 | 0.220 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2017 | 301 | 0.220 |
Why?
|
| Antigens, Neoplasm | 1 | 2024 | 137 | 0.220 |
Why?
|
| Neuroblastoma | 1 | 2024 | 52 | 0.220 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2017 | 281 | 0.220 |
Why?
|
| Tumor Microenvironment | 2 | 2024 | 152 | 0.210 |
Why?
|
| Chemokines | 1 | 2024 | 95 | 0.210 |
Why?
|
| Keratinocytes | 1 | 2023 | 65 | 0.210 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2023 | 75 | 0.210 |
Why?
|
| Mice | 6 | 2024 | 10739 | 0.200 |
Why?
|
| Hair Follicle | 1 | 2023 | 35 | 0.200 |
Why?
|
| Tetraploidy | 1 | 2022 | 2 | 0.200 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2022 | 12 | 0.200 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 171 | 0.200 |
Why?
|
| Cytokinesis | 1 | 2022 | 39 | 0.190 |
Why?
|
| Epithelial Cells | 1 | 2024 | 388 | 0.190 |
Why?
|
| Trans-Activators | 1 | 2004 | 308 | 0.190 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 255 | 0.190 |
Why?
|
| Cell Count | 1 | 2021 | 129 | 0.180 |
Why?
|
| Mammals | 1 | 2023 | 217 | 0.180 |
Why?
|
| Helminth Proteins | 1 | 2001 | 46 | 0.180 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 8 | 0.170 |
Why?
|
| Base Sequence | 2 | 2017 | 1329 | 0.170 |
Why?
|
| Cell Movement | 1 | 2021 | 445 | 0.160 |
Why?
|
| Biopsy | 1 | 2021 | 429 | 0.160 |
Why?
|
| Research Design | 1 | 2022 | 571 | 0.150 |
Why?
|
| Cell Cycle Proteins | 1 | 2001 | 394 | 0.150 |
Why?
|
| Cloning, Molecular | 2 | 2014 | 384 | 0.140 |
Why?
|
| Splenomegaly | 1 | 2017 | 24 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 2 | 2017 | 365 | 0.140 |
Why?
|
| Thymocytes | 1 | 2017 | 21 | 0.140 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2017 | 6 | 0.140 |
Why?
|
| Cell Lineage | 4 | 2017 | 265 | 0.140 |
Why?
|
| Mice, Nude | 1 | 2017 | 268 | 0.140 |
Why?
|
| Genes, p53 | 2 | 2015 | 52 | 0.140 |
Why?
|
| In Situ Hybridization | 1 | 2017 | 217 | 0.140 |
Why?
|
| Genes, Reporter | 1 | 2017 | 256 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2004 | 1498 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2017 | 195 | 0.130 |
Why?
|
| Phylogeny | 1 | 2017 | 366 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 711 | 0.130 |
Why?
|
| Blotting, Western | 1 | 2017 | 607 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2017 | 569 | 0.130 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 1988 | 0.130 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 48 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 891 | 0.120 |
Why?
|
| Adult Stem Cells | 1 | 2015 | 28 | 0.120 |
Why?
|
| Kidney | 1 | 2017 | 444 | 0.120 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 239 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 78 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 199 | 0.110 |
Why?
|
| Chronic Disease | 1 | 2017 | 740 | 0.110 |
Why?
|
| Female | 6 | 2021 | 32274 | 0.110 |
Why?
|
| Wound Healing | 1 | 2015 | 187 | 0.110 |
Why?
|
| Disease Progression | 2 | 2020 | 1159 | 0.110 |
Why?
|
| RNA | 1 | 2017 | 420 | 0.110 |
Why?
|
| Open Reading Frames | 1 | 2014 | 84 | 0.110 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 868 | 0.110 |
Why?
|
| Mitosis | 1 | 2015 | 218 | 0.110 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 92 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2015 | 973 | 0.100 |
Why?
|
| Cytosine | 1 | 2012 | 31 | 0.100 |
Why?
|
| Chromatin | 1 | 2017 | 616 | 0.100 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 761 | 0.100 |
Why?
|
| Phenotype | 3 | 2008 | 1188 | 0.100 |
Why?
|
| Staining and Labeling | 1 | 2012 | 126 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 1600 | 0.090 |
Why?
|
| Genes, Homeobox | 1 | 2011 | 24 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2011 | 22 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 667 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5381 | 0.090 |
Why?
|
| Inflammation | 1 | 2017 | 1135 | 0.090 |
Why?
|
| Age of Onset | 1 | 2011 | 175 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 1592 | 0.080 |
Why?
|
| Nuclear Proteins | 3 | 2008 | 770 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 146 | 0.080 |
Why?
|
| Blood Physiological Phenomena | 1 | 2009 | 1 | 0.080 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 669 | 0.080 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 20 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 376 | 0.080 |
Why?
|
| DNA-Binding Proteins | 4 | 2016 | 1176 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2009 | 72 | 0.080 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2008 | 8 | 0.070 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2008 | 27 | 0.070 |
Why?
|
| Microinjections | 1 | 2008 | 68 | 0.070 |
Why?
|
| Allelic Imbalance | 1 | 2007 | 6 | 0.070 |
Why?
|
| Polyploidy | 1 | 2007 | 11 | 0.070 |
Why?
|
| Wnt Proteins | 1 | 2008 | 97 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 297 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2014 | 830 | 0.070 |
Why?
|
| Stem Cell Transplantation | 1 | 2008 | 78 | 0.070 |
Why?
|
| Histone Deacetylases | 2 | 2006 | 63 | 0.070 |
Why?
|
| Chromosome Aberrations | 1 | 2007 | 67 | 0.070 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 70 | 0.070 |
Why?
|
| DNA, Helminth | 1 | 2006 | 9 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 109 | 0.060 |
Why?
|
| Genetic Linkage | 1 | 2006 | 95 | 0.060 |
Why?
|
| Heterozygote | 1 | 2006 | 168 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 310 | 0.060 |
Why?
|
| Aged | 1 | 2021 | 14158 | 0.060 |
Why?
|
| Alleles | 1 | 2006 | 443 | 0.060 |
Why?
|
| Organoids | 1 | 2024 | 42 | 0.060 |
Why?
|
| Male | 2 | 2021 | 29271 | 0.060 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2004 | 10 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2004 | 112 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2004 | 166 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 59 | 0.050 |
Why?
|
| Adult | 1 | 2021 | 16525 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 160 | 0.050 |
Why?
|
| Middle Aged | 1 | 2021 | 17237 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2024 | 372 | 0.050 |
Why?
|
| Liver | 1 | 2008 | 833 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2004 | 363 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2022 | 33 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2003 | 317 | 0.050 |
Why?
|
| E2F Transcription Factors | 1 | 2001 | 16 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 428 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 224 | 0.040 |
Why?
|
| Triglycerides | 1 | 2022 | 244 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2022 | 293 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 107 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2001 | 303 | 0.040 |
Why?
|
| Cell Division | 1 | 2001 | 450 | 0.040 |
Why?
|
| Transgenes | 2 | 2011 | 186 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2012 | 323 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2021 | 242 | 0.040 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 49 | 0.040 |
Why?
|
| Survival Rate | 1 | 2020 | 836 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2001 | 622 | 0.030 |
Why?
|
| Protein Binding | 1 | 2001 | 1595 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 170 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2148 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 1704 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2016 | 184 | 0.030 |
Why?
|
| Neurons | 1 | 2001 | 907 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2016 | 216 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 886 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2012 | 21 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2012 | 25 | 0.020 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2012 | 25 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 1004 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 360 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2009 | 22 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2009 | 19 | 0.020 |
Why?
|
| Rhabdomyosarcoma | 1 | 2009 | 16 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 157 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2008 | 19 | 0.020 |
Why?
|
| Cleavage Stage, Ovum | 1 | 2008 | 5 | 0.020 |
Why?
|
| Genes, bcl-2 | 1 | 2008 | 9 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 168 | 0.020 |
Why?
|
| Genes, myc | 1 | 2008 | 17 | 0.020 |
Why?
|
| Albinism | 1 | 2008 | 1 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2009 | 173 | 0.020 |
Why?
|
| Endoderm | 1 | 2008 | 47 | 0.020 |
Why?
|
| Body Patterning | 1 | 2008 | 81 | 0.020 |
Why?
|
| beta Catenin | 1 | 2008 | 92 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2008 | 63 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 55 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2008 | 129 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 165 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 105 | 0.020 |
Why?
|
| Light | 1 | 2008 | 201 | 0.020 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2006 | 17 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2006 | 187 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2008 | 214 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2008 | 669 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 155 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 1627 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 1062 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2006 | 1142 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 3368 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 3734 | 0.010 |
Why?
|